Daniel D.
- Country
- Germany
- Department
- Medizinische Klinik III
Research Overview
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of MBS2320 in Idiopathic Pulmonary Fibrosis Patients
- Evaluation of Treprostinil Palmitil Inhalation Powder on Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study
- Evaluation of Inhaled Colistimethate Sodium in Adult Bronchiectasis Patients with Asymptomatic Pseudomonas aeruginosa Infection: A Randomized Controlled Trial
Data & Insights
Has run more than one trial at 26 of 107 partner sites.
Specializations
Pulmonary Vascular Disorders
The investigator specializes in treating pulmonary arterial hypertension (PAH), focusing on innovative therapeutic approaches through inhalation-based treatments. Their research encompasses evaluation of novel medications for managing pulmonary vascular resistance.
- PAH Treatment Optimization
- Inhalation Therapy Assessment
- Long-term Disease Management
Their work extends to examining sustained therapeutic interventions for PAH patients, with particular attention to treatment tolerability and safety profiles.
Respiratory Infections
The investigator conducts research in the treatment of bronchiectasis, particularly focusing on patients with Pseudomonas aeruginosa infections. Their work involves evaluating innovative inhalation therapies for respiratory tract infections.
- Bronchiectasis Management
- Bacterial Infection Control
- Airway Clearance Strategies
Their expertise includes assessment of targeted therapeutic approaches for managing chronic respiratory infections.
Interstitial Lung Disease
The investigator focuses on treating idiopathic pulmonary fibrosis (IPF), exploring oral therapeutic interventions to improve lung function. Their research evaluates the impact of treatments on forced vital capacity in IPF patients.
- IPF Treatment Development
- Lung Function Assessment
- Progressive Disease Management
Their work encompasses evaluation of novel therapeutic compounds for managing progressive pulmonary fibrosis.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.